The rate of opioid use disorder diagnoses among commercially insured patients rose 32.7% nationwide between 2022 and 2025, ...

Adults with schizophrenia and Type 2 diabetes who started a glucagon-like peptide-1 receptor agonist were less likely to be ...

The Washington Poison Center warned the public Oct. 6 that some supplements sold as cat’s claw are counterfeit products ...

The National Labor Relations Board has issued a consolidated complaint against Rogers Memorial Hospital, which operates as ...

Nebraska’s Department of Health and Human Services has proposed eliminating 38 beds across two state psychiatric hospitals ...

Pittsburgh-based UPMC Western Psychiatric Hospital ranked No. 7 on U.S. News & World Report’s 2026-27 Best Hospitals for ...

The Texas Health and Human Services Commission has proposed cutting all funding for the Children’s Autism Program in its 2028 ...

The Drug Enforcement Administration is monitoring emerging threats from potent synthetic substances, including nitazenes and ...

Evidence is growing that GLP-1 receptor agonists, the drugs best known for treating diabetes and obesity, could also have a ...

HHS recommended new limits Oct. 9 to determine which kratom products fall under federal opioid controls. The goal is to ...

Frequent mental distress among young U.S. adults declined for the second consecutive year in 2024, though prevalence remained ...

Birmingham, Ala.-based Bradford Health Services has named Jason Langley president, a newly established position within the ...